Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Xian-Jie Yu"'
Publikováno v:
Journal of Materials Research and Technology, Vol 32, Iss , Pp 1937-1945 (2024)
Aluminum alloy materials are the primary choice for lightweight components. High-velocity compaction (HVC) enhances the density of diverse materials. This study utilizes HVC to enhance the density of aluminum alloy. This work examined the influence o
Externí odkaz:
https://doaj.org/article/ba29c9407577465e8c3f2ea4199f884d
Publikováno v:
Infection International, Vol 2, Iss 4, Pp 183-186 (2013)
Objective Nucleos(t)ide analogues (NAs) naïve chronic hepatitis B(CHB) patients were given rescue combination therapy after drug resistance to lamivudine or adefovir. Evolution of HBV mutation patterns and its impact on antiviral effects were studie
Autor:
Stephanie Roth, Edmond J. LaVoie, Cecile Rouleau, Xian-Jie Yu, Min Yao, Rebecca G. Bagley, Leslie Kurtzberg, Fei Wang, Beverly A. Teicher, Steven Schmid, Jennifer Crawford, Naoki Agata, Traci Battle, Roy Krumbholz, Reginald Ewesuedo
Publikováno v:
Molecular Cancer Therapeutics. 7:3212-3222
Topoisomerase I (TopoI), an established anticancer target, is an enzyme producing a single-strand DNA break during transcription. Several noncamptothecin TopoI inhibitors have been identified. One of these, ARC-111, was compared with two clinically u
Autor:
Michael A. Moskowitz, Xian-Jie Yu
Publikováno v:
British Journal of Pharmacology. 119:229-232
1. The effects of neuropeptide Y (NPY) receptor agonists (administered intravenously) were examined on plasma protein ([125I]-bovine serum albumin) leakage within dura mater evoked by unilateral trigeminal ganglion stimulation (0.6 mA, 5 ms, 5 Hz, 5
Autor:
Michael A. Moskowitz, Cenk Ayata, Volker Limmroth, Won Suk Lee, Xian-Jie Yu, Christian Waeber, F. M. Cutrer
Publikováno v:
British Journal of Pharmacology. 116:1661-1667
1. The GABA transaminase inhibitor and activator of glutamic acid decarboxylase, valproic acid is being used for the treatment of migraine. Its mechanism of action is unknown. We tested the effects of sodium valproate and GABAA-agonist muscimol on du
Publikováno v:
Life Sciences. 54:753-758
In the present study, the concentration of NG,NG-dimethylarginine (DMA), an endogenous inhibitor of nitric oxide synthesis, was measured with high-performance liquid chromatography, and the effect of hypercholesterolemia on DMA level was investigated
Autor:
Leslie Kurtzberg, Christy Bormann, Xian-Jie Yu, Steven Schmid, Jennifer Crawford, Fei Wang, Edmond J. LaVoie, Rebecca G. Bagley, Roy Krumbholz, Beverly A. Teicher, Cecile Rouleau, Sarah Dunham, Ming Yao, Stephanie Roth
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 17(9)
Purpose: Genz-644282 [8,9-dimethoxy-5-(2-N-methylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-one] has emerged as a promising candidate for antitumor agents. This report describes the bone marrow colony-forming unit, granulocyte
Autor:
Margarette S. Kolczak, Feifei Wei, K. Arnold Chan, David K. Shay, John P. Mullooly, Ken Kleinman, Tracy A. Lieu, Nancy D. Lin, Steven Black, Xian-Jie Yu
Publikováno v:
BMC Pediatrics, Vol 6, Iss 1, p 31 (2006)
BMC Pediatrics
BMC Pediatrics
Background In 1999, the American Academy of Pediatrics and U.S. Public Health Service recommended suspending the birth dose of hepatitis B vaccine due to concerns about potential mercury exposure. A previous report found that overall national hepatit
Autor:
Ken Kleinman, Alexander J. McAdam, Megan A. O'Brien, Xian-Jie Yu, William W. Thompson, David K. Shay, Tracy A. Lieu, Timothy M. Uyeki, Richard Platt
Publikováno v:
Pediatrics. 113(3 Pt 1)
Objective. The Advisory Committee on Immunization Practices currently encourages influenza vaccination for all children aged 6 to 23 months when feasible, based on studies that have demonstrated that young children have high hospitalization rates att
Publikováno v:
Neuropharmacology. 38(7)
We studied the effects of PNU-109291 [(S)-(-)-1-[2-[4-(4-methoxyphenyl)-1-piperazinyl]ethyl]-N-methyl-isoc hroman-6-carboxamide], a receptor agonist showing 5000-fold selectivity for primate 5-HT1D versus 5-HT1B receptors (Ennis et al., J. Med. Chem.